es By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
es By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Today - InvestorPlace.com
Oxygen Biotherapeutics (OXBT) Is Today's Perilous Reversal Stock 9:58 a.m. Nov. 15, 2013 - TheStreet.com
Today's Dead Cat Bounce Stock: Oxygen Biotherapeutics (OXBT) 9:45 a.m. Nov. 14, 2013 - TheStreet.com
4 Stock Jumps You Missed While Ogling the Twitter IPO 3:03 a.m. Nov. 12, 2013 - InvestorPlace.com
Oxygen Biotherapeutics Announces $6M in Net Proceeds from Exercise of Warrants 6:43 a.m. Nov. 8, 2013 - benzinga.com
Oxygen Biotherapeutics (OXBT) Showing Signs Of A Dead Cat Bounce Today 9:45 a.m. Nov. 7, 2013 - TheStreet.com
Watch Out: Barbarians At The Gate For Oxygen Biotherapeutics (OXBT) 10:27 a.m. Nov. 5, 2013 - TheStreet.com
UPDATE: Oxygen Biotherapeutics Reports Deal to Buy Phase 3, FDA Fast-Track Designated Levosimendan from Phyxius Pharma 2:47 p.m. Oct. 21, 2013 - benzinga.com
10-Q: OXYGEN BIOTHERAPEUTICS, INC. 4:05 p.m. Sept. 17, 2013 - Edgar Online - (EDG = 10Q, 10K)
Oxygen Biotherapeutics Sends Letter to Holds, Discusses Progress, Prelim. Results in Trials 6:33 a.m. Aug. 7, 2013 - benzinga.com
Oxygen Biotherapeutics Prices Public Offering with Gross Proceeds of $5.4 Million 6:32 a.m. July 22, 2013 - benzinga.com
Oxygen Biotherapeutics Announces Progress in its Phase IIb Clinical Trial of Oxycyte for the Treatment of Traumatic Brain Injury 6:46 a.m. July 1, 2013 - benzinga.com
Oxygen Biotherapeutics Makes Recent Progress In An Under-Met Indication 2:16 p.m. June 28, 2013 - Seeking Alpha
10-K: OXYGEN BIOTHERAPEUTICS, INC. 3:17 p.m. June 26, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech Movers: Chelsea Doubles, Vivus Dips 3:15 a.m. Feb. 25, 2013 - InvestorPlace.com
Oxygen Biotherapeutics Announces Deal for Up to $2.1M in Financing 8:00 a.m. Feb. 22, 2013 - benzinga.com
Oxygen Biotherapeutics Reports Tentative Settlement of Litigation 10:05 a.m. Feb. 20, 2013 - benzinga.com
Oxygen Biotherapeutics Announces License, Supply Deal for Dermacyte Products with Valor Cosmetics Unit 4:16 p.m. Feb. 11, 2013 - benzinga.com
Oxygen Biotherapeutics, US Army ISR Sign Cooperative R&D Deal to Study Effects of Oxycyte on Ex Vivo Platelet Function 7:33 a.m. Feb. 6, 2013 - benzinga.com
10-Q: OXYGEN BIOTHERAPEUTICS, INC. 4:41 p.m. Dec. 14, 2012 - Edgar Online - (EDG = 10Q, 10K)


Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax 8:00 a.m. Nov. 19, 2013 - PR Newswire
Oxygen Biotherapeutics Closes the Acquisition of Phyxius Pharma Assets Related to Levosimendan; John Kelley Appointed CEO of Oxygen Biotherapeutics 7:45 a.m. Nov. 14, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
OXBT, HZNP, PPHM and NWBO added to NASDAQ Healthcare Stock Watch List at GSR 10:35 a.m. Nov. 11, 2013 - ACCESSWIRE
Oxygen Biotherapeutics Receives $6 Million in Net Proceeds from Warrant Exercises 7:25 a.m. Nov. 8, 2013 - BusinessWire
Oxygen Biotherapeutics (OXBT) Rise Sheds Light On OxySure Systems (OXYS) 12:00 p.m. Nov. 7, 2013 - ACCESSWIRE
Acquisitions, Project Announcements & Trend Analysis News for Oxygen Biotherapeutics, Glu Mobile, Cisco Systems, Barrick Gold, CVS Caremark 8:48 a.m. Nov. 6, 2013 - PR Newswire
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
SmallCapTraders.Com Initiates Coverage of (NASDAQ: OXBT) and Issues Micro Cap Watch List 6:01 a.m. Nov. 1, 2013 - Marketwire
Phyxius Pharma in Conjunction with Oxygen Biotherapeutics Announces New Evidence That Levosimendan Can Reduce Mortality in Heart Surgery Patients 8:59 a.m. Oct. 30, 2013 - BusinessWire
Phyxius Pharma in Conjunction with Oxygen Biotherapeutics Announces New Evidence That Levosimendan Can Reduce Mortality in Heart Surgery Patients 7:45 a.m. Oct. 30, 2013 - BusinessWire
Commencement of Clinical Trials, Financial Results, Upcoming Earnings Releases, and Asset Acquisitions - Research Report on Questcor, Jazz Pharmaceuticals, Ariad, and USANA 7:00 a.m. Oct. 25, 2013 - PR Newswire
MDVN, OXBT, PTIE and SYMM added to NASDAQ Active Stock Watch List at EPR 8:30 a.m. Oct. 23, 2013 - ACCESSWIRE
Oxygen Biotherapeutics Signs Agreement to Acquire Phase 3, FDA Fast Track Product to Pursue Potential $600 Million Cardiovascular Market 3:45 p.m. Oct. 21, 2013 - BusinessWire
Oxygen Biotherapeutics Submits to FDA Results of Requested Nonclinical Studies 8:24 a.m. Sept. 23, 2013 - BusinessWire
Oxygen Biotherapeutics to Present at Aegis Capital Healthcare Conference in Las Vegas on September 27, 2013 7:45 a.m. Sept. 19, 2013 - BusinessWire
Oxygen Biotherapeutics Strengthens Balance Sheet Through $4.6 Million Debt Conversion 8:00 a.m. Sept. 18, 2013 - BusinessWire
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 7:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Oxygen Biotherapeutics Issued U.S. Patent for Dermatologic Indications 8:00 a.m. Sept. 10, 2013 - BusinessWire
CORRECTING and REPLACING Oxygen Biotherapeutics Issues Letter to Shareholders 11:13 a.m. Aug. 7, 2013 - BusinessWire

$OXBT News

The roller-coaster stock in health care that is Oxygen Biotherapeutics 12:54 p.m. Nov. 6, 2013 - Russ Britt
Big earnings Friday: Rick’s Cabaret, Ocean Power 5:30 a.m. Dec. 14, 2012 - MarketWatch
Oxygen Biotherapeutics names new chairman 8:55 a.m. Oct. 1, 2011 - MarketWatch.com
Oxygen Bio chief faked resume, audit body shows 2:46 p.m. Sept. 26, 2011 - MarketWatch.com

UNIS Stock Explod
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 7

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 4

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 4

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 0

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 2

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 2

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 3

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 4

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 3

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 4

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading

Top 5 Most Recently Viewed Articles

Yesway Expands Reach with New Allsup's Stores Opening

Updated Category News Views 166

Yesway Takes Significant Steps in Store Expansion Yesway, a prominent player in the convenience retail sector, is rapidly expanding its network by introducing four new Allsup's stores in key regions. This strategic move marks another milestone in Yesway's commitment to growing its business and enhancing customer experiences. New Stores in Promising Markets The recent...

Continue Reading
IR Spectroscopy Market Growth: Projected USD 2 Billion by 2032

Updated Category News Views 171

IR Spectroscopy Market Insights and Future Growth Growing trends in technology and application expansion are driving significant changes in the IR spectroscopy market, which was valued at USD 1.3 billion recently. This market is projected to surpass USD 2 billion by the end of this decade. One of the primary contributors to this growth is the miniaturization and...

Continue Reading
Flow Capital Expands Investment in MiniLuxe's Growth Journey

Updated Category News Views 142

Flow Capital Expands Investment in MiniLuxe Flow Capital Corp. (TSXV:FW), a prominent player in providing alternative debt solutions and flexible growth capital, has reaffirmed its commitment to MiniLuxe Holding Corp. (TSXV: MNLX) with a substantial follow-on investment of US$1.675 million. This marks the third investment from Flow Capital into MiniLuxe, bringing the...

Continue Reading
Exploring the Expansive Pipeline of NLRP3 Protein Inhibitors

Updated Category News Views 326

An Overview of NLRP3 Protein Inhibitors The NLRP3 protein inhibitors are paving the way for new therapeutic avenues aimed at mitigating chronic inflammatory conditions. This approach targets a significant piece of the innate immune system, specifically the NOD-like receptor family pyrin domain-containing 3 (NLRP3), known for its involvement in myriad diseases. These...

Continue Reading
Sanara MedTech Engages Investors at Key Healthcare Conference

Updated Category News Views 106

Sanara MedTech's Participation at Major Healthcare Conference Sanara MedTech Inc. (Nasdaq: SMTI), a leader in medical technology, is excited to announce its upcoming participation in a significant healthcare conference held at The Lotte New York Palace. This event showcases innovative advancements aimed at enhancing surgical outcomes and addressing healthcare costs,...

Continue Reading